Atea Pharmaceuticals Inc. (AVIR)
2.97
-0.03 (-1.00%)
At close: Apr 17, 2025, 3:59 PM
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for AVIR stock have an median target of 6, with a low estimate of 6 and a high estimate of 6. The median target predicts an increase of 102.02% from the current stock price of 2.97.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Atea Pharmaceuticals Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
7.08M
from 0
Increased by -%
Revenue Next Year
8.6M
from 7.08M
Increased by 21.5%
EPS This Year
-1.7
from -2
Increased by 15.0%
EPS Next Year
-1.69
from -1.7
Increased by 0.6%